SRC and glioblastoma: The consistent activation of the EGFR/SRC/ERK pathway in GBM cells results in the upregulation of YTHDF2, which in turn downregulates liver X receptor A (LXRA) and hivep zinc finger 2 (HIVEP2) mRNA expression, thereby promoting GBM cell proliferation [116].